Skip to main content
logo
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
29.40
-0.29 (-0.98%)
At close: Oct 29, 2025, 4:00 PM EDT
29.60
+0.20 (0.68%)
After-hours: Oct 29, 2025, 4:07 PM EDT

Rigel Pharmaceuticals Revenue

Rigel Pharmaceuticals had revenue of $101.69M in the quarter ending June 30, 2025, with 176.01% growth. This brings the company's revenue in the last twelve months to $267.92M, up 105.62% year-over-year. In the year 2024, Rigel Pharmaceuticals had annual revenue of $179.28M with 54.71% growth.

Revenue (ttm)
$267.92M
Revenue Growth
+105.62%
P/S Ratio
1.97
Revenue / Employee
$1,633,665
Employees
164
Market Cap
525.92M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024179.28M63.40M54.71%
Dec 31, 2023115.88M140.00K0.12%
Dec 31, 2022115.74M-22.99M-16.57%
Dec 31, 2021138.74M30.12M27.72%
Dec 31, 2020108.62M49.33M83.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

RIGL News

More News